Brief: Trevi Therapeutics Announces Closing Of $173 Million Underwritten Offering
20/04/2026 21:18
April 20 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS ANNOUNCES CLOSING OF $173 MILLION UNDERWRITTEN OFFERING AND FULL EXERCISE BY UNDERWRITERS OF OPTION TO PURCHASE ADDITIONAL SHARES Source text: ID:nGNX5YYFzY Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million